Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study
- 1 May 2015
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 110 (5) , 708-715
Abstract
Double-blind study comparing efficacy and safety of the topically acting corticosteroid beclomethasone dipropionate (BDP) to prednisone (PD) in patients with active, mild-to-moderate ulcerative colitis (UC). Overall, 282 patients were randomized to receive BDP-prolonged release tablets 5 mg once daily for 4 weeks and then every other day for an additional 4 weeks or oral PD 40 mg once daily for the initial 2 weeks tapered of 10 mg every 2 weeks during the 8-week study period. Efficacy end point was the non-inferiority of BDP vs. PD in terms of Disease Activity Index (DAI) score <3 or reduction by at least 3 points for patients with a baseline DAI ≥7 at week 4. Safety end point was the proportion of patients with steroid-related adverse events (AEs) and cortisol <150 nmol/l at week 4. DAI response rates at week 4 were 64.6% and 66.2% with BDP and PD, respectively, demonstrating non-inferiority of BDP vs. PD (delta: -1.56; 95% confidence interval (CI) -13.00-9.88, P=0.78). Patients with steroid-related AEs and cortisol <150 nmol/l at week 4 were 38.7% in the BDP group and 46.9% in the PD group (P=0.17 between groups). No safety signals were observed in both the groups. BDP was non-inferior to PD in the treatment of active UC, with a good safety profile in both the groups.Keywords
This publication has 23 references indexed in Scilit:
- Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II studyGut, 2013
- Oral Beclomethasone Dipropionate in Pediatric Active Ulcerative Colitis: A Comparison Trial With MesalazineJournal of Pediatric Gastroenterology and Nutrition, 2010
- Conventional RIA underestimates cortisol suppression in the presence of prednisoloneThorax, 2002
- Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in manBritish Journal of Clinical Pharmacology, 2001
- Oral budesonide is as effective as oral prednisolone in active Crohn’s diseaseGut, 1997
- Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitisGastroenterology, 1996
- The in vivo behaviour of a colonic delivery system: a pilot study in manInternational Journal of Pharmaceutics, 1994
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative ColitisBMJ, 1962